How to Avoid Adverse Events During Apixaban Therapy in Patients With Atrial Fibrillation
Circ J
.
2015;79(12):2539-40.
doi: 10.1253/circj.CJ-15-1097.
Epub 2015 Oct 29.
Authors
Masashi Kanemoto
1
,
Yasuhiro Ikeda
,
Takashi Fujii
Affiliation
1
Department of Cardiology, Yamaguchi Grand Medical Center.
PMID:
26511463
DOI:
10.1253/circj.CJ-15-1097
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants
Atrial Fibrillation / drug therapy*
Humans
Stroke / chemically induced*
Warfarin
Substances
Anticoagulants
Warfarin